Bian et al. also reported that loss of p16INK4a expression, tumor size, lymph node metastasis, and pathological stages are associated with significantly shorter OS in lung ADC [55]. The gene discussed is CDKN2A; the disease is metastatic malignant neoplasm in the lymph nodes.